SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    Popular Searches

    • Glass Pharms
    • medical
    • Medical Cannabis
    • Cannabis Health Symposium
    • Kanabo Calls in Administrators
    • Article
    • antiflamx near me abbotsford bc
    • teaching feeling scene
    • for driving licence test
    • LEADER AM

    Recent Searches

      Popular Searches

      • Glass Pharms
      • medical
      • Medical Cannabis
      • Cannabis Health Symposium
      • Kanabo Calls in Administrators
      • Article
      • antiflamx near me abbotsford bc
      • teaching feeling scene
      • for driving licence test
      • LEADER AM
      Cultivation, Videos, Your #1 Podcast on Cannabis News

      Andrew Grieve, CEO, Zenabis $ZENA

      By
      BofC

      Andrew Grieve, CEO of Zenabis, joined Jay Rosenthal for BofC Live to talk about their $30 million Prepaid Supply Agreement (PSA) with Tilray.

      BofC

      Other featured articles

      Cannavigia Become’s Watter’s Exclusive Commercial Partner, Brining Continuous Water Disinfection Technology to European Cannabis

      By

      Dutch Cannabis Patients Facing 10-Month Supply Gap, Many With ‘No Therapeutic Alternative’

      By

      Why Pharmaceutical Standards Matter More Than Cannabis Branding

      By

      What APAC Producers Get Wrong About EU-GMP

      By

      Are US Cannabis Contracts Enforceable? A $32m Court Ruling Just Said No

      By

      Other featured Cultivation articles

      Why Pharmaceutical Standards Matter More Than Cannabis Branding

      By

      What APAC Producers Get Wrong About EU-GMP

      By

      Are US Cannabis Contracts Enforceable? A $32m Court Ruling Just Said No

      By

      France’s PGP Farmer Selects 5 Cannabis Strains for Future French Production as Market Nears Rollout

      By

      Are We Underestimating the Pharmaceutical Potential of the Cannabis Plant?

      By

      Share Article

      The Briefing / Newsletter

      Insights
      you don't want
      to miss.

      A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.

      • Policy & regulation
      • Markets & deals
      • Clinical & science
      Subscribe free

      Related news

      Press releases
      Cannavigia Become’s Watter’s Exclusive Commercial Partner, Brining Continuous Water Disinfection Technology to European Cannabis

      By

      Medical Cannabis Netherlands
      Supply Chain
      Dutch Cannabis Patients Facing 10-Month Supply Gap, Many With ‘No Therapeutic Alternative’

      By

      James Duckenfield
      Pharmaceutical
      Why Pharmaceutical Standards Matter More Than Cannabis Branding

      By

      Opinion
      What APAC Producers Get Wrong About EU-GMP

      By

      Legal Analysis
      Are US Cannabis Contracts Enforceable? A $32m Court Ruling Just Said No

      By

      Business
      France’s PGP Farmer Selects 5 Cannabis Strains for Future French Production as Market Nears Rollout

      By

      James Duckenfield
      Opinion
      Are We Underestimating the Pharmaceutical Potential of the Cannabis Plant?

      By

      Cultivation
      Inside Northern Leaf’s Remarkable Turnaround: From Brink of Collapse to £8m Cultivator

      By

      James Duckenfield
      Cultivation
      The Science of the Cannabis Post-Harvest Process 

      By